This comprehensive review aimed to evaluate the relationship between SARS-CoV-2
infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and …

In Covid-19, variations in fasting blood glucose are considered a distinct risk element for a
bad prognosis and outcome in Covid-19 patients. Tirazepatide (TZT), a dual glucagon-like …

Reactive oxygen species (ROS) are radical oxygen intermediates that serve as important
second messengers in signal transduction. However, when the accumulation of these …

Several studies provide evidence that obesity is a significant risk factor for adverse
outcomes in coronavirus disease 2019 (COVID-19). Altered renal function and disturbances …

Exercise is an integral part of metabolic syndrome (MetS) treatment. Recently, low-volume
high-intensity interval training (LOW-HIIT) has emerged as a time-efficient approach to …

Exercise is a cornerstone in metabolic syndrome (MetS) treatment. However, the effects of
low-volume exercise modalities on MetS-associated low-grade inflammation are unclear. A …

IJMS | Free Full-Text | Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes:
Current Knowledge and Future Avenues Next Article in Journal Incretins in the Therapy of …

Background Obesity is a risk factor for COVID-19 severity. Recent studies suggest that prior
metabolic surgery (MS) modifies the risk of COVID-19 severity. Methods COVID-19 …

The activation of endothelial cells is crucial for immune defense mechanisms but also plays
a role in the development of atherosclerosis. We have previously shown that inflammatory …

In the current COVID-19 pandemic scenario, it is still necessary to understand if differences
exist between genders in terms of patients' characteristics and clinical outcomes. For this …